Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Cancer Immunotherapy Market to Cross US$ 145 Billion by 2022

Market Research Engine
Posted on: 21 Oct 16
Cancer Immunotherapy Market to Cross US$ 145 Billion by 2022

New York, October 21: Market Research Engine has published a new report titled as “Cancer Immunotherapy Market by Type (Immunomodulators, Checkpoint inhibitors, Cancer vaccines, Monoclonal antibodies), By Application (Melanoma, Colorectal cancer, Prostate cancer, Head and Neck cancer, Breast cancer, Lung cancer) and by End Users – Global Industry Analysis and Forecast 2016 - 2022”

 

How Big is the Cancer Immunotherapy Market?

The cancer immunotherapy market is expected to grow more than US$ 145 Billion by 2022; Growing at a CAGR of more than 14% in the given forecast period.
 

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/cancer-immunotherapy-market

 

Immunotherapy is a treatment which uses particular parts of person’s immune organism to fight against cancer. Immune system is a collection of special cells, organs and substance which protect us from diseases and infections. Immune cells and the substances that make set out through your body to shield it from germs that cause diseases. The immune system monitors the majority of the substances typically found in the body. Any new substance that the immune system doesn't perceive raises an alert, creating the resistant framework to assault it. Cancer immunotherapy is a medicine that outfit and upgrade the inborn forces of the immune system to battle tumor which represents the most encouraging new disease treatment approach since the improvement of the principal chemotherapies in the late 1940s.


The major driving factors of cancer immunotherapy market are as follows:

    Expansion of bioinformatics tools will enhance drug development procedure
    Growth in adoption of immunotherapy above other treatment alternatives
    Increase in incidence rate of cancer worldwide

The restraining factors of cancer immunotherapy market are as follows:

    Treatment cost is high

The cancer immunotherapy market is segmented on the lines of its type, application, end user and regional. Based on type segmentation it covers immunomodulators, checkpoint inhibitors, cancer vaccines and monoclonal antibodies. Under application segmentation it covers melanoma, colorectal cancer, prostate cancer, head and neck cancer, breast cancer and lung cancer. The cancer immunotherapy market is segmented on the lines of its end user like clinics and others hospitals.The cancer immunotherapy marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/cancer-immunotherapy-market

 

This report provides:

1) An overview of the global market for cancer immunotherapy and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Discovering of new market opportunities and targeted promotional plans for cancer immunotherapy.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Cancer Immunotherapy market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Amgen (U.S.), AstraZeneca (U.K.), F. Hoffman La-Roche Ltd. (Switzerland), Bayer AG (Germany), Bristol-Myers Squibb (U.S.), Eli Lilly and Company (U.S.), Janssen Global Services, LLC (Belgium), Merck (U.S.), Novartis (Switzerland), and Pfizer (U.S.).. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Cancer Immunotherapy Market has been segmented as below:  

By Type Segment Analysis

Immunomodulators
Checkpoint inhibitors
Cancer vaccines
Monoclonal antibodies

By Application Analysis

Melanoma
Colorectal cancer
Prostate cancer
Head and neck cancer
Breast cancer
Lung cancer

By End-user Analysis

Hospitals
Clinics and others

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World
 

For more information:
www.marketresearchengine.com

Editor's Details

John Bay
Market Research Engine
www.marketresearchengine.com
1-855-984-1862
john@marketresearchengine.com

Last updated on: 21/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.